by Tim Olmstead | Dec 21, 2021 | Uncategorized
Insights Our Blog The Crossroads of 340B and Biosimilars: Challenges and Opportunities If you are a hospital or pharmacy provider, it’s no surprise that the growth of biologic drug spending (14.6%) was more than double the growth of overall drug spending (6.1%)...
by Tim Olmstead | Dec 3, 2021 | Uncategorized
Insights Our Blog Jamila Seibel Spotlight How long have you been a part of the Alinea-Group? I started with Alinea in 2015. What brought you to the company? I have known Shrujal Patel, one of the founding partners, since 1998 when I started pharmacy school. I like to...
